publication date: Dec 3, 2013
Patients receiving chemotherapy in hospital outpatient departments face up to 47 percent higher costs compared to patients treated in physician community cancer clinics, according to a report prepared by The Moran Company and released by The US Oncology Network and the Community Oncology Alliance.
Titled “Cost Differences in Cancer Care Across Settings,” the report analyzes Centers for Medicare and Medicaid Services data from 2009 to 2011.
The report focuses on payment rate differentials between cancer clinics and hospitals due to differences in the utilization of drugs and services, as well as methodologies employed by Medicare to set payment rates.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.